Undetected Omicron Transmission in Romania—Report of the First Detected Case of Locally Acquired Omicron Infection and Complete Epidemiological Investigation
Anca Streinu-Cercel,
Oana Săndulescu,
Victor Daniel Miron,
Simona Paraschiv,
Corina Casangiu,
Robert Hohan,
Leontina Bănică,
Marius Surleac,
Adrian Streinu-Cercel
Affiliations
Anca Streinu-Cercel
Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
Oana Săndulescu
Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
Victor Daniel Miron
Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
Simona Paraschiv
Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
Corina Casangiu
National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, 021105 Bucharest, Romania
Robert Hohan
National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, 021105 Bucharest, Romania
Leontina Bănică
National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, 021105 Bucharest, Romania
Marius Surleac
National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, 021105 Bucharest, Romania
Adrian Streinu-Cercel
Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
The occurrence of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has importantly impacted surveillance and diagnosis, and has changed the therapeutic landscape of coronavirus disease 2019 (COVID-19). We present the first documented case of locally acquired SARS-CoV-2 omicron variant in Romania in a patient with no recent travel outside the country. We also present the full results of the epidemiological investigation that led to the identification of the index case in a co-worker who had developed mild symptoms shortly after returning from the UK and who had undergone multiple rapid antigen tests with negative results prior to being tested by RT-PCR. We highlight potential lessons learned and describe further directions for actionable research and development in the field of COVID-19.